UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis

Annals of neurology, 2000-12, Vol.48 (6), p.885-892

2000

Volltextzugriff (PDF)

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Multiple sclerosis, 2005-08, Vol.11 (4), p.409-419

2005

Volltextzugriff (PDF)

Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis

Neurology, 2004-12, Vol.63 (11 Suppl 5), p.S19

2004

Volltextzugriff (PDF)

A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis

Allergy and asthma proceedings, 2005-11, Vol.26 (6), p.470

2005

Volltextzugriff (PDF)

Structure-Based Discovery of Nonpeptidic Small Organic Compounds To Block the T Cell Response to Myelin Basic Protein

Journal of medicinal chemistry, 2004-10, Vol.47 (21), p.4989-4997

2004

Volltextzugriff (PDF)

Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis

Gene, 2004-10, Vol.341 (C), p.235-247

2004

Volltextzugriff (PDF)

Sp3 Expression in Immune Cells: A Quantitative Study

Laboratory investigation, 2002-09, Vol.82 (9), p.1131-1138

2002

Volltextzugriff (PDF)

Role of an internal ribosome entry site in the translational control of the human transcription factor Sp3

International journal of oncology, 2004-03, Vol.24 (3), p.719

2004

Volltextzugriff (PDF)

AUA as a translation initiation site in vitro for the human transcription factor Sp3

BMB reports, 2002-05, Vol.35 (3), p.273-282

2002

Volltextzugriff (PDF)

Localization of the human SP3 gene to chromosome 7p14–p15.2. The lack of expression in multiple sclerosis does not reflect abnormal gene organization

Journal of neuroimmunology, 2000-07, Vol.106 (1), p.214-219

2000

Volltextzugriff (PDF)

Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults

The Pediatric infectious disease journal, 1994-01, Vol.13 (1), p.34-37

1994

Volltextzugriff (PDF)

Open label gabapentin treatment for pain in multiple sclerosis

Multiple sclerosis, 1997-08, Vol.3 (4), p.250-253

1997

Volltextzugriff (PDF)

CSF antibodies for dynorphin bind synthetic staphylococcus aureus replication protein B 275–290

Biological psychiatry (1969), 1994-10, Vol.36 (7), p.482-484

1994

Volltextzugriff (PDF)

Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen

The Journal of immunology (1950), 1979-02, Vol.122 (2), p.494-496

1979

Volltextzugriff (PDF)

Demyelination occurring during anti-tumor necrosis factor a therapy for inflammatory arthritides

Arthritis and rheumatism, 2001-12, Vol.44 (12), p.2862-2869

2001

Volltextzugriff (PDF)

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106

The Journal of immunology (1950), 1992-03, Vol.148 (5), p.1359-1366

1992

Volltextzugriff (PDF)

Multiple Sclerosis: Current Status of Research and Treatment

Neurology, 1995-06, Vol.45 (6), p.1241

Richert, John R.

1995

Volltextzugriff (PDF)

EAE susceptibility in FVB mice

Journal of neuroscience research, 2000-07, Vol.61 (2), p.140-145

2000

Volltextzugriff (PDF)

Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosis

Multiple sclerosis, 2005, Vol.11 (4), p.409-419

2005

Volltextzugriff (PDF)

Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13

The Journal of immunology (1950), 1996-10, Vol.157 (8), p.3460-3471

1996

Volltextzugriff (PDF)

Differential recognition of MBP epitopes in BALB/c mice determines the site of inflammatory disease induction

Journal of neuroimmunology, 1998-08, Vol.89 (1), p.73-82

1998

Volltextzugriff (PDF)

Deficient expression in multiple sclerosis of the inhibitory transcription factor SP3 in mononuclear blood cells

Annals of neurology, 1996-07, Vol.40 (1), p.108-112

1996

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(83)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis

Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis

A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis

Structure-Based Discovery of Nonpeptidic Small Organic Compounds To Block the T Cell Response to Myelin Basic Protein

Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis

Sp3 Expression in Immune Cells: A Quantitative Study

Role of an internal ribosome entry site in the translational control of the human transcription factor Sp3

AUA as a translation initiation site in vitro for the human transcription factor Sp3

Localization of the human SP3 gene to chromosome 7p14–p15.2. The lack of expression in multiple sclerosis does not reflect abnormal gene organization

Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis

Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults

Open label gabapentin treatment for pain in multiple sclerosis

CSF antibodies for dynorphin bind synthetic staphylococcus aureus replication protein B 275–290

Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen

Demyelination occurring during anti-tumor necrosis factor a therapy for inflammatory arthritides

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis

Multiple Sclerosis: Current Status of Research and Treatment

EAE susceptibility in FVB mice

Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosis

Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13

Differential recognition of MBP epitopes in BALB/c mice determines the site of inflammatory disease induction

Deficient expression in multiple sclerosis of the inhibitory transcription factor SP3 in mononuclear blood cells

Suchergebnisse filtern